An2 Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.3M | 394k | 3.42 |
| 2024-12-31 | $532k | 386k | 1.38 |
| 2024-09-30 | $17k | 16k | 1.07 |
| 2024-06-30 | $34k | 16k | 2.15 |
| 2024-03-31 | $49k | 15k | 3.25 |
| 2023-12-31 | $449k | 22k | 20.49 |
| 2023-09-30 | $50k | 3.1k | 16.08 |
| 2023-06-30 | $104k | 12k | 8.50 |
| 2023-03-31 | $256k | 26k | 9.87 |
| 2022-12-31 | $236k | 25k | 9.53 |
| 2022-06-30 | $13k | 1.6k | 7.93 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation